Ian Scott Young is a prominent inventor based in Redwood City, CA. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work primarily focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention related to amorphous and crystalline forms of IDO inhibitors. This patent discusses the compound (R)—N-(4-chlorophenyl)-2-(1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide and its salts and hydrates. It also covers processes for their production, pharmaceutical compositions that include these compounds, and methods of treatment utilizing them. Another notable patent involves substituted quinolinylcyclohexylpropanamide compounds, focusing on improved methods for their preparation.

Career Highlights

Ian Scott Young is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in developing new compounds has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Ian has collaborated with several talented individuals, including Hilary Plake Beck and Maksim Osipov. These collaborations have further enhanced his research and development efforts.

Conclusion

Ian Scott Young's innovative work in the pharmaceutical sector exemplifies the impact of dedicated inventors on healthcare advancements. His patents reflect a commitment to improving treatment options through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.